Back to Search Start Over

RNA expression differences in prostate tumors and tumor-adjacent stroma between Black and White Americans.

Authors :
Rahmatpanah F
Robles G
Lilly M
Keane T
Kumar V
Mercola D
Randhawa P
McClelland M
Source :
Oncotarget [Oncotarget] 2021 Jul 20; Vol. 12 (15), pp. 1457-1469. Date of Electronic Publication: 2021 Jul 20 (Print Publication: 2021).
Publication Year :
2021

Abstract

Prostate cancer (PCa) in Black Americans (BA) is diagnosed at an earlier median age and a more advanced stage than PCa in White Americans (WA). Tumor-adjacent stroma (TAS) plays a critical role in tumorigenesis of prostate cancer. We examined RNA expression in both tumor and TAS of BA compared to WA. After evaluating the geographical ancestry of each sample, preliminary analysis of our own RNA-seq data of 7 BA and 7 WA TAS revealed 1706 downregulated and 1844 upregulated genes in BA relative to WA PCa patients ( p <subscript>adj</subscript> < 0.05). An assessment of published RNA-seq data of clinically matched tumor-enriched tissues from 15 BA and 30 WA patients revealed 932 upregulated and 476 downregulated genes in BA relative to WA ( p <subscript>adj</subscript> < 0.05). When TAS and tumor epithelial cohorts were compared for the top 2500 statistically significant genes, immune responses were downregulated in BA vs WA TAS, while T cell-exhaustion pathways and the immune checkpoint gene CTLA4 were upregulated in BA vs WA tumors. We found fewer activated dendritic cells in tumor and more CD8 T-cells in TAS of BA versus WA PCa patients. Further characterization of these differences in the immune response of PCa patients of distinct geographical ancestry could help to improve diagnostics, prognostics, and therapy.<br />Competing Interests: CONFLICTS OF INTEREST Authors have no conflicts of interest to declare.<br /> (Copyright: © 2021 Rahmatpanah et al.)

Details

Language :
English
ISSN :
1949-2553
Volume :
12
Issue :
15
Database :
MEDLINE
Journal :
Oncotarget
Publication Type :
Academic Journal
Accession number :
34316327
Full Text :
https://doi.org/10.18632/oncotarget.28024